BLACK WEEKSLiekovky −15 % · kity −10 % · ostatné −5 %s kódomDoprava po Nemecku zadarmo od 200 €

Táto stránka bola preložená automaticky a môže obsahovať chyby. Ste rodený hovoriaci? Radi privítame vašu spätnú väzbu a opravy.Poslať spätnú väzbu

The Peptide Desk The Peptide Desk
Reta + Cagri Blend, fotografia produktu
GLP-1

Reta + Cagri Blend

GLP-1

  • Odosielame z Nemecka

Objednávka

Cena za kus - Doprava po Nemecku zadarmo od 200 € počas Black Weeks
  • DHL so sledovaním zásielky
  • Diskrétne balenie

4.6 z 5 na Trustpilote73 hodnotení

V skratke

Reta + Cagri Blend v číslach

Kľúčové údaje z nášho lexikónu.

Celé heslo v lexikóne
Class
Triple agonistGLP-1 / GIP / glucagon, + amylin analog
Half-life
Retatrutide around 6 dayscagrilintide around 7 to 8 days
Form
Lyophilisatepowder, reconstituted with BAC water
Sizes
30 mg1 size in the shop

Pre Reta + Cagri Blend zatiaľ neexistuje laboratórna analýza. Hlasujte za toDajte si to otestovať sami, polovicu zaplatímeVšetky laboratórne analýzy

Znalosti

Všetko o Reta + Cagri Blend

Hodí sa priobjednať

Čo k tomu potrebujete

Bakteriostatická voda sa do košíka pridá automaticky. Striekačky a tampóny jedným kliknutím.

Inzulínové striekačky

10 ks · 5.50 €

Alkoholové tampóny

50 ks · 10 €

Koľko vody?

Jednotky na striekačke pre vašu veľkosť liekovky.

Otvoriť kalkulačku →

FAQ

Časté otázky

Zdroje ku každej odpovedi: heslo v lexikóne

Máte ešte otázku?

Napíšte nám, náš tím vám pomôže.

Is the Reta + Cagri Blend approved or studied?

No. As of 26 October 2026 the registry ClinicalTrials.gov lists no trial with Retatrutide and cagrilintide together. Both components are in phase 3 and not approved.

Why Retatrutide and cagrilintide together?

Both act on different satiety pathways: Retatrutide on GLP-1, GIP and glucagon, cagrilintide on amylin receptors. With semaglutide as the partner, weight loss in a phase 1b trial after 20 weeks was 17.1 instead of 9.8 percent. For Retatrutide as the partner there are no data.

What do the studies of the components show?

Retatrutide alone: in TRIUMPH-1 after 80 weeks 25.0 percent less body weight on average at the highest study dose, 3.9 percent on placebo. Cagrilintide alone: up to 10.8 percent after 26 weeks in phase 2, 3.0 percent on placebo. In a substudy liver fat also fell sharply on Retatrutide.

Why is the cagrilintide share so small?

The vial contains five times as much Retatrutide as cagrilintide, because Retatrutide is the stronger and limiting part. Anyone going by the Retatrutide share stays far below the amounts used in the cagrilintide trials. Whether the small share contributes anything has not been studied.

How long do the components stay in the body?

Retatrutide had a half-life of about six days in a phase 1b study, cagrilintide 159 to 195 hours in another study, so about a week. Both fit one dose per week.

Which side effects were seen with the components?

With both, mainly gastrointestinal effects such as nausea and diarrhoea, depending on the dose. On Retatrutide heart rate rose in a dose-dependent way in phase 2. Two satiety signals together may strengthen nausea at the start, this has not been measured for this blend.

Which trials are still running?

Nine phase 3 trials of Retatrutide are running, the largest on heart and kidney events until 2029. The RENEW trials of cagrilintide alone run until 2027. No trial of the blend is listed in the registry.

Súvisiace

Súvisiace produkty